Zobrazeno 1 - 10
of 500
pro vyhledávání: '"Eng-Eong Ooi"'
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 3, Pp 551-560 (2017)
A cohort of 81 HIV-infected participants received seasonal trivalent inactivated influenza vaccine (TIV) and their humoral responses were monitored using hemagglutination inhibition (HAI) assay and enzyme-linked immunosorbent assay (ELISA). Three wee
Externí odkaz:
https://doaj.org/article/528566708b604916809bea20f81b672d
Publikováno v:
Emerging Infectious Diseases, Vol 12, Iss 6, Pp 887-893 (2006)
After a 15-year period of low incidence, dengue has reemerged in Singapore in the past decade. We identify potential causes of this resurgence. A combination of lowered herd immunity, virus transmission outside the home, an increase in the age of inf
Externí odkaz:
https://doaj.org/article/c41989aa298b4cab861901b9c58ac20e
Publikováno v:
Emerging Infectious Diseases, Vol 8, Iss 9, Pp 995-997 (2002)
Human enterovirus 71 has caused outbreaks in many parts of the world, especially Southeast Asia, with some fatal cases. The epidemiology of this viral infection is not well understood. We conducted a serologic survey in Singapore children, and the re
Externí odkaz:
https://doaj.org/article/85db8a7a66ec43a0a9e7af1aa5b0345e
Autor:
Lisa F P Ng, Angela Chow, Yong-Jiang Sun, Dyan J C Kwek, Poh-Lian Lim, Frederico Dimatatac, Lee-Ching Ng, Eng-Eong Ooi, Khar-Heng Choo, Zhisheng Her, Philippe Kourilsky, Yee-Sin Leo
Publikováno v:
PLoS ONE, Vol 4, Iss 1, p e4261 (2009)
BackgroundLittle is known about the immunopathogenesis of Chikungunya virus. Circulating levels of immune mediators and growth factors were analyzed from patients infected during the first Singaporean Chikungunya fever outbreak in early 2008 to estab
Externí odkaz:
https://doaj.org/article/be13d69a4f7349cfb9001a109c5fd7b5
Autor:
Eng-Eong Ooi, Duane J. Gubler
Publikováno v:
Cadernos de Saúde Pública, Vol 25, Pp S115-S124 (2009)
Dengue emerged as a public health burden in Southeast Asia during and following the Second World War and has become increasingly important, with progressively longer and more frequent cyclical epidemics of dengue fever/dengue hemorrhagic fever. Despi
Externí odkaz:
https://doaj.org/article/35a95a1b13124377af7db28ed223fa51
Publikováno v:
Emerging Infectious Diseases, Vol 12, Iss 3, Pp 525-526 (2006)
Externí odkaz:
https://doaj.org/article/a19fd76a74304dc783d3ddd45a752b55
Autor:
Pierce K. H. Chow, Eng-Eong Ooi, Hiang-Khoon Tan, Kong-Wee Ong, Bijon Kumar Sil, Melissa Teo, Timothy Ng, Khee-Chee Soo
Publikováno v:
Emerging Infectious Diseases, Vol 10, Iss 2, Pp 249-250 (2004)
Serum samples were obtained from healthcare workers 5 weeks after exposure to an outbreak of severe acute respiratory syndrome (SARS). A sensitive dot blot enzyme-linked immunosorbent assay, complemented by a specific neutralization test, shows that
Externí odkaz:
https://doaj.org/article/063462b76a894718807292288f30f7b0
Autor:
Chaminda Jayampath Seneviratne, Preethi Balan, Ruklanthi de Alwis, Nadeeka S. Udawatte, Thanuja Herath, Justin Z.N. Toh, Goh Bee Tin, Eng Eong Ooi, Jenny Low Guek Hong, Jean Sim Xiang Ying
Publikováno v:
International Dental Journal. 73:435-442
The COVID-19 vaccine is currently being administered worldwide to address the ongoing pandemic. Although these vaccines have proven effective in preventing severe disease, the level of immunity required to prevent respiratory mucosal infection remain
Autor:
Shirin Kalimuddin, Yvonne F. Z. Chan, October M. Sessions, Kuan Rong Chan, Eugenia Z. Ong, Jenny G. Low, Antonio Bertoletti, Eng Eong Ooi
Publikováno v:
Frontiers in Immunology. 14
Vaccination induces an adaptive immune response that protects against infectious diseases. A defined magnitude of adaptive immune response that correlates with protection from the disease of interest, or correlates of protection (CoP), is useful for
Autor:
Youjia Zhong, Kuan Rong Chan, Carina Tay, Zi Wei Chia, Hui’ En Li, Tanamas Siriphanitchakorn, Eugenia Ong, Yan Shan Leong, Alicia Kang, Regena Chua, Gaik Chin Yap, Chiung-Hui Huang, Joey Lim, Anthony Tan, Jenny Low, Lynette Shek, Elizabeth Tham, Eng Eong Ooi
For improved safety, children are vaccinated with a lower dose and extended interval for mRNA COVID-19 vaccines; however, whether there is protection before dose 2 is unknown. We recruited 113 children receiving BNT162b2 primary vaccination during an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::047accb081a9edd9eb9f42d0282d7c6b
https://doi.org/10.21203/rs.3.rs-2421432/v1
https://doi.org/10.21203/rs.3.rs-2421432/v1